The Latest

This Week in HIV Research: A Bite of the Apple

June 20, 2019: Housing stability and HIV viremia; how the stigma of poverty affects viral load; the best time to employ syringe services; promise for the practice of index testing.

By Barbara Jungwirth and Myles Helfand

Hormonal Contraception Does Not Increase HIV Risk, Study Finds

No meaningful difference was found in either injectable or implant birth control when compared to an IUD.

By Sony Salzman

Ending the HIV Epidemic Will Take More Than Medicine

Our HIV research agenda has to address the world outside of a clinical trial, vaccine researcher Stephaun E. Wallace, Ph.D., argues.

By Stephaun E. Wallace, Ph.D.

This Week in HIV Research: A Test of Resistance

May 16, 2019: The dwindling value of baseline genotype testing; severe insomnia and cardiovascular disease; cardiovascular risk stratified by sex among people over 50; the persistence of racial disparities among women diagnosed with HIV.

By Barbara Jungwirth and Myles Helfand

Making Trans Women Count in HIV Vaccine Trials

"For us who focus on HIV prevention research, it is paramount that we go where the epidemic is in this country," said Michele Andrasik, Ph.D.

By Stephen Hicks

This Week in HIV Research: Disparities Drive the Epidemic

April 25, 2019: stigma and viral load among African-American women; U.S. HIV incidence sans racial disparities; the care continuum is failing young MSM; a moment of reckoning regarding HIV among U.S. youth.

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: Fentanyl Smooths the Path for HIV

April 4, 2019: what’s driving the HIV outbreak in northeastern Massachusetts; race-gender HIV disparities among Baltimore sex workers; high PrEP interest, low awareness among southern black women; naltrexone implants for opioid dependence.

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: Transgender Women in the Spotlight

Black transgender women and the HIV care continuum; PrEP uptake potential among trans women; an update on U.S. mother-to-child HIV transmission; is extra measles vaccination necessary?

By Barbara Jungwirth and Myles Helfand

How Does the Microbiome Impact HIV Risk and Treatment?

The vaginal, anal, and gut microbiome regions are now the focus of intense HIV-related research, with potentially wide-ranging implications stretching from prevention to patient care.

By Sony Salzman

Going to USCA Was My Form of Self-Care

"More than a conference, it is a family reunion and place to network and learn, but most importantly uplift each other," Maria Mejia writes.

By Maria T. Mejia for The Well Project